Smoking Cessation 12 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet — RxCUI 1801289
RxNorm drug concept · Semantic clinical drug
RxCUI 1801289
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
13 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1801289
Official nameSmoking Cessation 12 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbupropion HCl 150 MG Smoking Cessation 12 HR Extended Release Oral Tablet; buPROPion HCl 150 MG Smoking Cessation 12HR Extended Release Oral Tablet
FDA products mapped6
Package NDCs mapped13
Reported Medicaid activity (SDUD)29,598 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Bupropion: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Bupropion treats major depressive disorder. Some extended-release products, like Aplenzin and bupropion XL, can also prevent seasonal affective disorder, the depression that return...
- Take it by mouth exactly as prescribed. XL tablets are taken once in the morning, with or without food, and must be swallowed whole. Your doctor will usually raise the dose gradual...
- The most common ones are dry mouth, nausea, trouble sleeping, dizziness, headache, anxiety and tremor. Call your doctor right away if you have a seizure, new suicidal thoughts, sev...
- It's best to limit or avoid alcohol. Rare neuropsychiatric events and lower alcohol tolerance have been reported. Never suddenly stop heavy drinking while on bupropion without talk...
🕸️ Concept Web — How Smoking Cessation 12 HR bupropion hydrochloride... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Smoking Cessation 12 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet
RxCUI 1801289 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Bupropion
42347IN -
Bupropion hydrochloride
203204PIN
-
Bupropion
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Bupropion Extended Release Oral Tablet
378354SCDF -
Bupropion hydrochloride Extended Release Oral Tablet
2648043SCDFP -
Bupropion Oral Product
1151365SCDG -
Bupropion Pill
1151366SCDG -
Bupropion hydrochloride Oral Product
2659331SCDGP -
Bupropion hydrochloride Pill
2661650SCDGP -
Extended Release Oral Tablet
316945DF -
Oral Product
1151131DFG - +1 more in this family
-
Bupropion Extended Release Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Bupropion hydrochloride 150 MG
993517SCDC
-
Bupropion hydrochloride 150 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Bupropion hydrochloride 150 MG
SCDC · 993517 -
Bupropion Extended Release Oral Tablet
SCDF · 378354 -
Bupropion hydrochloride Extended Release Oral Tablet
SCDFP · 2648043 -
Bupropion Oral Product
SCDG · 1151365 -
Bupropion Pill
SCDG · 1151366 -
Bupropion hydrochloride Oral Product
SCDGP · 2659331 -
Bupropion hydrochloride Pill
SCDGP · 2661650
📦 FDA Products & Package NDCs
6 products · 13 package NDCs
13 package NDCs map to RxCUI 1801289 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00591-3543-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Bupropion Hydrochloride SR | Actavis Pharma, Inc. | 2009-06-11 |
| 00591-3543-76 | 1 BOTTLE, PLASTIC in 1 CARTON (0591-3543-76) / 60 TABLET, F... | Bupropion Hydrochloride SR | Actavis Pharma, Inc. | 2009-08-25 |
| 42806-0413-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42806-... | Bupropion Hydrochloride SR | Epic Pharma, LLC | 2023-02-28 |
| 43598-0863-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-10) | BUPROPION HYDROCHLORIDE (SR) | Dr. Reddy's Laboratories Inc | 2016-08-17 |
| 43598-0863-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-30) | BUPROPION HYDROCHLORIDE (SR) | Dr. Reddy's Laboratories Inc | 2016-08-17 |
| 43598-0863-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-60) | BUPROPION HYDROCHLORIDE (SR) | Dr. Reddy's Laboratories Inc | 2016-08-17 |
| 50090-1150-00 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Bupropion Hydrochloride SR | A-S Medication Solutions | 2014-11-28 |
| 50090-1150-01 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-... | Bupropion Hydrochloride SR | A-S Medication Solutions | 2014-11-28 |
| 50090-5101-00 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-0) | BUPROPION HYDROCHLORIDE (SR) | A-S Medication Solutions | 2020-07-13 |
| 50090-5101-01 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-1) | BUPROPION HYDROCHLORIDE (SR) | A-S Medication Solutions | 2020-07-13 |
| 50228-0338-11 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAS... | Bupropion Hydrochloride (SR) | ScieGen Pharmaceuticals, Inc. | 2019-05-01 |
| 50228-0338-31 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Bupropion Hydrochloride (SR) | ScieGen Pharmaceuticals, Inc. | 2019-05-01 |
| 50228-0338-61 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Bupropion Hydrochloride (SR) | ScieGen Pharmaceuticals, Inc. | 2019-05-01 |
Observed labelers:
A-S Medication Solutions (4) ·
Dr. Reddy's Laboratories Inc (3) ·
ScieGen Pharmaceuticals, Inc. (3) ·
Actavis Pharma, Inc. (2) ·
Epic Pharma, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.